Cargando…

Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant

PURPOSE: This analysis assesses clinical characteristics of patients with refractory chronic cough (RCC) or unexplained chronic cough (UCC) enrolled in a phase 2 study to better understand this patient population. METHODS: Patients with RCC/UCC lasting for ≥ 1 year and cough severity visual analog s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morice, Alyn H., Birring, Surinder S., Smith, Jaclyn A., McGarvey, Lorcan P., Schelfhout, Jonathan, Martin Nguyen, Allison, Xu, Zhi Jin, Wu, Wen-Chi, Muccino, David R., Sher, Mandel R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Cough
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053171/ https://www.ncbi.nlm.nih.gov/pubmed/33825965 http://dx.doi.org/10.1007/s00408-021-00437-7

Ejemplares similares

Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined Subgroups
por: Smith, Jaclyn A., et al.
Publicado: (2022)

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough
por: McGarvey, Lorcan, et al.
Publicado: (2022)

The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic Cough
por: McGarvey, Lorcan, et al.
Publicado: (2023)

Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks
por: Birring, Surinder S., et al.
Publicado: (2023)

Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough
por: Muccino, David R., et al.
Publicado: (2020)

Validation and Meaningful Change Thresholds for an Objective Cough Frequency Measurement in Chronic Cough
por: Schelfhout, Jonathan, et al.
Publicado: (2022)

Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study
por: Dicpinigaitis, Peter V., et al.
Publicado: (2023)

Chronic cough: new insights and future prospects
por: Morice, Alyn, et al.
Publicado: (2021)

Sound: a non-invasive measure of cough intensity
por: Lee, Kai K, et al.
Publicado: (2017)

Objective and Subjective Measurement of Cough in Asthma: A Systematic Review of the Literature
por: Holmes, Joshua, et al.
Publicado: (2022)

Leicester Cough Questionnaire validation and clinically important thresholds for change in refractory or unexplained chronic cough
por: Nguyen, Allison Martin, et al.
Publicado: (2022)

Comprehensive evidence-based review on European antitussives
por: Morice, Alyn, et al.
Publicado: (2016)

Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study
por: Morice, Alyn, et al.
Publicado: (2021)

Web-based survey to evaluate the prevalence of chronic and subacute cough and patient characteristics in Japan
por: Tobe, Keisuke, et al.
Publicado: (2021)

Disease burden and quality of life of patients with chronic cough in Japan: a population-based cross-sectional survey
por: Kubo, Takekazu, et al.
Publicado: (2021)

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
por: McGarvey, Lorcan, et al.
Publicado: (2016)

The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial
por: Friedrich, Christian, et al.
Publicado: (2023)

Domiciliary Cough Monitoring for the Prediction of COPD Exacerbations
por: Crooks, Michael G., et al.
Publicado: (2021)

Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study
por: Dávila, Ignacio, et al.
Publicado: (2023)

The Relationship Between Cough Reflex Sensitivity and Exacerbation Frequency in Chronic Obstructive Pulmonary Disease
por: Cho, Peter S. P., et al.
Publicado: (2020)

Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough
por: Mazzone, Stuart B., et al.
Publicado: (2020)

Treating acute cough: wet versus dry – have we got the paradigm wrong?
por: Morice, Alyn H., et al.
Publicado: (2015)

Cough Characteristics and Healthcare Journeys of Chronic Cough Patients in Community-Based Populations in South Korea and Taiwan
por: Song, Woo-Jung, et al.
Publicado: (2022)

CT airway remodelling and chronic cough
por: Abozid, Hazim, et al.
Publicado: (2023)

Cough in the Elderly During the COVID-19 Pandemic
por: Kaulamo, Johanna Tuulikki, et al.
Publicado: (2022)

Recurrent Cough in the Elderly: A Forgotten Entity
por: Kaulamo, Johanna Tuulikki, et al.
Publicado: (2023)

From bench to bedside: The role of cough hypersensitivity in chronic cough
por: Drake, Matthew G., et al.
Publicado: (2023)

Cough Sensitivity to Several External Triggers is Associated with Multiple Non-respiratory Symptoms
por: Koskela, Heikki O., et al.
Publicado: (2023)

Healthcare-Seeking Behaviour Due to Cough in Finnish Elderly: Too Much and Too Little
por: Kaulamo, Johanna Tuulikki, et al.
Publicado: (2023)

A Survey of Physicians' Perception of the Use and Effectiveness of Diagnostic and Therapeutic Procedures in Chronic Cough Patients
por: Puente-Maestu, Luis, et al.
Publicado: (2021)

The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group Study
por: Smith, Jaclyn A., et al.
Publicado: (2019)

Efficacy of Gefapixant, a P2X(3) Antagonist, for Refractory Atopic Cough
por: Ishiura, Yoshihisa, et al.
Publicado: (2023)

Self-reported symptoms of chronic cough and breathlessness in working-age men in the city of Izhevsk, Russia: associations with cardiovascular disease risk factors and comorbidities
por: Cook, Sarah, et al.
Publicado: (2015)

Measuring cough: what really matters?
por: Turner, Richard Douglas, et al.
Publicado: (2023)

Burden of chronic cough in the UK: results from the 2018 National Health and Wellness Survey
por: McGarvey, Lorcan, et al.
Publicado: (2023)

Cough hypersensitivity and chronic cough
por: Chung, Kian Fan, et al.
Publicado: (2022)

Validation of a visual analog scale for assessing cough severity in patients with chronic cough
por: Martin Nguyen, Allison, et al.
Publicado: (2021)

Chronic cough—the limitation and advances in assessment techniques
por: Zhang, Mengru, et al.
Publicado: (2022)

Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough
por: Ludbrook, Valerie J., et al.
Publicado: (2021)

An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma
por: Holmes, Joshua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8srqrip1gkm6vlpvfab53equrd